Immunohistochemical staining in each group. by Yue Yang (52715)

“…<p>Increase in the frequency with same amount of treadmill exercise decreased the MIA-induced degradation of COL2A1 in articular cartilage and reduced the expression of MMP-13 and NF-κB p65. …”

A visual example of DV-misclassification relationships and the results of the statistical simulations. by Alexander J. Millner (817690)

“…The red and green arrows in (A) and (B) represent data points that will be misclassified due to participants inaccurately categorizing their suicidal behavior. …”

Kaplan Meier curves of OS and PFS according to d-dimer values comparing OS rates between patients with D-dimer levels ≤ 0.3 µg/mL and those with levels > 0.3 µg/mL. by Huriye Senay Kiziltan (22298378)

Tamoxifen induction at E11.5 causes overproduction of oversized, innervated taste buds in <i>ShhCreER</i>^<i>T2</i><i>/Shh</i>^<i>f</i> mutant tongues. by Maha El Shahawy (557888)

“…(<b>A,B</b>) <i>In situ</i> hybridization with a riboprobe targeting <i>Shh</i> exon2 (the deleted allele) in E13.5 control (A) and mutant (B) tongues showing severely decreased <i>Shh</i> expression (purple) in the mutant tongue. …”

CPA treatment lowered activated caspase 3 and GFAP levels while DPCPX increased activated Caspase 3 and GFAP levels. by Manuel Soliño (5410001)

“…F) Quantification of C3a by WB. DPCPX produced a highly significant rise in C3a relative density compared to CTL (1.85±0.5 vs 1.01±0.07; unpaired Student´s t-test; p<0.01; n = 4), **p<0.01.…”

ATP levels show transient changes with exposure to DHA. by Arlet Hernandez (12289155)

Oxidative phosphorylation is also reduced after 7 mM DHA exposure. by Arlet Hernandez (12289155)

RssB is produced during phosphate starvation dependent upon RpoS. by Sophie Bouillet (18137403)

Data_Sheet_1_Gut microbiota of preterm infants in the neonatal intensive care unit: a study from a tertiary care center in northern India.docx by Prabavathi Devarajalu (17929847)

“…DNA was extracted using a DNeasy Powersoil DNA isolation kit. 16S rRNA gene sequencing targeting the V3–V4 region was performed using the MiSeq platform. …”

A comprehensive study of glucose and oxygen gradients in a scaled-down model of recombinant HuGM-CSF production in thermoinduced <i>Escherichia coli</i> fed-batch cultures by Greta I. Reynoso-Cereceda (18501789)

“…</p> <p></p><p>Thermoinduced recombinant <i>E. coli</i> grew less in a two-compartment scale-down model.</p><p>Heat-inducible <i>E. coli</i> cultures at a large scale significantly decrease recombinant protein production.…”

Image_5_Clinical Outcomes Following Hemodynamic Parameter or Intravascular Imaging-Guided Percutaneous Coronary Intervention in the Era of Drug-Eluting Stents: An Updated Systemati... by Meng-Jin Hu (11928965)

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Table_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.docx by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_1_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_3_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Image_2_Modification of Intestinal Microbiota Dysbiosis by Low-Dose Interleukin-2 in Dermatomyositis: A Post Hoc Analysis From a Clinical Trial Study.jpeg by Yunzhi Zhufeng (10961908)

“…Low-dose IL-2 treatment emerges as a new option for active IIMs. This study aims to explore the role of low-dose IL-2 in regulating intestinal dysbiosis involved in the IIMs. …”

Knockdown of the β2-AR fails to prevent carvedilol-mediated inhibition of EGF-induced neoplastic transformation of JB6 P+ cells. by Kristan H. Cleveland (6714539)